References
- Global Initiative for Chronic Obstructive Lung Disease [webpage on the Internet]Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2016) Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016Accessed October 2016
- FitchKIwasakiKPyensonBPlauschinatCZhangJVariation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysisCurr Med Res Opin20112771425142921599554
- DalalAALiuFRiedelAACost trends among commercially insured and Medicare advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009Int J Chron Obstruct Pulmon Dis2011653354222069365
- DalalAARobertsMHPetersenHVBlanchetteCMMapelDWComparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis201161322
- DalalAAShahMLunacsekOHananiaNAClinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular diseaseRespir Med2011105101516152221684731
- HillKGoldsteinRSGuyattGHPrevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary careCMAJ2010182767367820371646
- JonesPLareauSMahlerDAMeasuring the effects of COPD on the patientRespir Med200599suppl BS11S18
- ManaliEDLyberopoulosPTriantafillidouCMRC chronic Dyspnea Scale: relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective studyBMC Pulm Med2010103220509928
- PaladiniLHodderRCecchiniIBelliaVIncalziRAThe MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patientsRespir Med201010471027103420116231
- StentonCThe MRC breathlessness scaleOccup Med (Lond)20085822622718441368
- JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- ReillyMCTannerAMeltzerEOWork, classroom and activity impairment instruments. Validation studies in allergic rhinitisClin Drug Invest199611278288
- StåhlEJanssonSAJonssonACSvenssonKLundbäckBAnderssonFHealth-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPDHealth Qual Life Outcomes200311812809558
- van der MolenTWillemseBWSchokkerSten HackenNHPostmaDSJuniperEFDevelopment, validity and responsiveness of the Clinical COPD QuestionnaireHealth Qual Life Outcomes200311312773199
- StällbergBNokelaMEhrsPOHjemdalPJonssonEWValidation of the Clinical COPD Questionnaire (CCQ) in primary careHealth Qual Life Outcomes200972619320988
- ParkersonGRBroadheadWETseCKThe Duke Health Profile. A 17-item measure of health and dysfunctionMed Care19902811105610722250492
- DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
- RabeKFImproving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategiesProc Am Thorac Soc20063327027516636097
- PunekarYSMullerovaHSmallMPrevalence and burden of dyspnoea among patients with chronic obstructive pulmonary disease in five European countriesPulmon Ther201625972
- KimSOhJKimYIDifferences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analysesBMC Pulm Med2013133523731868
- SrivastavaKThakurDSharmaSPunekarYSSystematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary diseasePharmacoeconomics201533546748825663178